Citations (33)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (33)
Jean-Marc Taymans, Matt Fell, Tim Greenamyre, Warren D. Hirst, Adamantios Mamais, Shalini Padmanabhan, Inga Peter, Hardy Rideout & Avner Thaler. (2023) Perspective on the current state of the LRRK2 field. npj Parkinson's Disease 9:1.
Crossref
Crossref
Yibo Zhao, Nikoleta Vavouraki, Ruth C. Lovering, Valentina Escott-Price, Kirsten Harvey, Patrick A. Lewis & Claudia Manzoni. (2023) Tissue specific LRRK2 interactomes reveal a distinct striatal functional unit. PLOS Computational Biology 19:1, pages e1010847.
Crossref
Crossref
Kelda Chia, Anna Klingseisen, Dirk Sieger & Josef Priller. (2022) Zebrafish as a model organism for neurodegenerative disease. Frontiers in Molecular Neuroscience 15.
Crossref
Crossref
Sachin Kumar, Tapan Behl, Aayush Sehgal, Sridevi Chigurupati, Sukhbir Singh, Vasudevan Mani, Maha Aldubayan, Ahmed Alhowail, Satvinder Kaur, Saurabh Bhatia, Ahmed Al-Harrasi, Vetriselvan Subramaniyan, Shivkanya Fuloria, Neeraj Kumar Fuloria, Mahendran Sekar & Mohamed M. Abdel Daim. (2022) Exploring the focal role of LRRK2 kinase in Parkinson’s disease. Environmental Science and Pollution Research 29:22, pages 32368-32382.
Crossref
Crossref
Pablo Caviedes, Raúl Caviedes & Juan Segura-Aguilar. 2022. Handbook of Neurotoxicity. Handbook of Neurotoxicity
239
254
.
Stefano Suzzi, Reiner Ahrendt, Stefan Hans, Svetlana A. Semenova, Avinash Chekuru, Paul Wirsching, Volker Kroehne, Saygın Bilican, Shady Sayed, Sylke Winkler, Sandra Spieß, Anja Machate, Jan Kaslin, Pertti Panula & Michael Brand. (2021) Deletion of lrrk2 causes early developmental abnormalities and age-dependent increase of monoamine catabolism in the zebrafish brain. PLOS Genetics 17:9, pages e1009794.
Crossref
Crossref
Pablo Caviedes, Raúl Caviedes & Juan Segura-Aguilar. 2021. Handbook of Neurotoxicity. Handbook of Neurotoxicity
1
16
.
Zhen Chen, Tuo Shao, Wei Gao, Hualong Fu, Thomas Lee Collier, Jian Rong, Xiaoyun Deng, Qingzhen Yu, Xiaofei Zhang, April T. Davenport, James B. Daunais, Hsiao‐Ying Wey, Yihan Shao, Lee Josephson, Wen‐Wei Qiu & Steven Liang. (2019)
Synthesis and Preliminary Evaluation of [
11
C]GNE‐1023 as a Potent PET Probe for Imaging Leucine‐Rich Repeat Kinase 2 (LRRK2) in Parkinson's Disease
. ChemMedChem 14:17, pages 1580-1585.
Crossref
Crossref
Elie Maksoud, Edward H. Liao & A. Pejmun Haghighi. (2019) A Neuron-Glial Trans-Signaling Cascade Mediates LRRK2-Induced Neurodegeneration. Cell Reports 26:7, pages 1774-1786.e4.
Crossref
Crossref
Thomas J. Lukas. 2018. Encyclopedia of Signaling Molecules. Encyclopedia of Signaling Molecules
1314
1321
.
Darcie A. Cook & Malú G. Tansey. 2017. Neuroimmune Pharmacology. Neuroimmune Pharmacology
107
116
.
Un-Beom Kang & Jarrod A. Marto. (2017) Leucine-rich repeat kinase 2 and Parkinson's disease. PROTEOMICS 17:1-2, pages 1600092.
Crossref
Crossref
Thomas J. Lukas. 2016. Encyclopedia of Signaling Molecules. Encyclopedia of Signaling Molecules
1
8
.
Anthony A. Estrada & Zachary K. Sweeney. (2015) Chemical Biology of Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitors. Journal of Medicinal Chemistry 58:17, pages 6733-6746.
Crossref
Crossref
Dayne A. Beccano-Kelly, Naila Kuhlmann, Igor Tatarnikov, Mattia Volta, Lise N. Munsie, Patrick Chou, Li-Ping Cao, Heather Han, Lucia Tapia, Matthew J. Farrer & Austen J. Milnerwood. (2014) Synaptic function is modulated by LRRK2 and glutamate release is increased in cortical neurons of G2019S LRRK2 knock-in mice. Frontiers in Cellular Neuroscience 8.
Crossref
Crossref
S Yang, C Xia, S Li, L Du, L Zhang & Y Hu. (2014) Mitochondrial dysfunction driven by the LRRK2-mediated pathway is associated with loss of Purkinje cells and motor coordination deficits in diabetic rat model. Cell Death & Disease 5:5, pages e1217-e1217.
Crossref
Crossref
Anthony A. Estrada, Bryan K. Chan, Charles Baker-Glenn, Alan Beresford, Daniel J. Burdick, Mark Chambers, Huifen Chen, Sara L. Dominguez, Jennafer Dotson, Jason Drummond, Michael Flagella, Reina Fuji, Andrew Gill, Jason Halladay, Seth F. Harris, Timothy P. Heffron, Tracy Kleinheinz, Donna W. Lee, Claire E. Le Pichon, Xingrong Liu, Joseph P. Lyssikatos, Andrew D. Medhurst, John G. Moffat, Kevin Nash, Kimberly Scearce-Levie, Zejuan Sheng, Daniel G. Shore, Susan Wong, Shuo Zhang, Xiaolin Zhang, Haitao Zhu & Zachary K. Sweeney. (2014) Discovery of Highly Potent, Selective, and Brain-Penetrant Aminopyrazole Leucine-Rich Repeat Kinase 2 (LRRK2) Small Molecule Inhibitors. Journal of Medicinal Chemistry 57:3, pages 921-936.
Crossref
Crossref
Pika Miklavc, Konstantin Ehinger, Kristin E. Thompson, Nina Hobi, Derya R. Shimshek & Manfred Frick. (2014) Surfactant Secretion in LRRK2 Knock-Out Rats: Changes in Lamellar Body Morphology and Rate of Exocytosis. PLoS ONE 9:1, pages e84926.
Crossref
Crossref
Paul Galatsis, Jaclyn Henderson, Bethany L. Kormos & Warren D. Hirst. 2014.
43
58
.
Pablo Caviedes, Raúl Caviedes & Juan Segura-Aguilar. 2014. Handbook of Neurotoxicity. Handbook of Neurotoxicity
95
108
.
Carolina Cebrián, John D. Loike & David Sulzer. 2015. Behavioral Neurobiology of Huntington's Disease and Parkinson's Disease. Behavioral Neurobiology of Huntington's Disease and Parkinson's Disease
237
270
.
Paul Galatsis, Jaclyn L. Henderson, Bethany L. Kormos & Warren D. Hirst. 2016. Novel Therapeutic Approaches to the Treatment of Parkinson’s Disease. Novel Therapeutic Approaches to the Treatment of Parkinson’s Disease
111
148
.
Haitao Zhu, Huifen Chen, William Cho, Anthony A. Estrada & Zachary K. Sweeney. 2013. Medicinal Chemistry Approaches to Personalized Medicine. Medicinal Chemistry Approaches to Personalized Medicine
227
254
.
C. Warren Olanow & Anthony H. V. Schapira. (2013) Therapeutic prospects for Parkinson disease. Annals of Neurology 74:3, pages 337-347.
Crossref
Crossref
Heinz Steiner. (2013) LRRKing up the right trees? On figuring out the effects of mutant LRRK2 and other Parkinson's disease-related genes. Basal Ganglia 3:2, pages 73-76.
Crossref
Crossref
Juliet M. Taylor, Bevan S. Main & Peter J. Crack. (2013) Neuroinflammation and oxidative stress: Co-conspirators in the pathology of Parkinson?s disease. Neurochemistry International 62:5, pages 803-819.
Crossref
Crossref
Zejuan ShengShuo ZhangDaisy BustosTracy KleinheinzClaire E. Le PichonSara L. DominguezHilda O. SolanoyJason DrummondXiaolin ZhangXiao DingFang CaiQinghua SongXianting LiZhenyu YueMarcel P. van der BrugDaniel J. BurdickJanet Gunzner-TosteHuifen ChenXingrong LiuAnthony A. EstradaZachary K. SweeneyKimberly Scearce-LevieJohn G. MoffatDonald S. KirkpatrickHaitao Zhu. (2012)
Ser
1292
Autophosphorylation Is an Indicator of LRRK2 Kinase Activity and Contributes to the Cellular Effects of PD Mutations
. Science Translational Medicine 4:164.
Crossref
Crossref
Anthony A. Estrada, Xingrong Liu, Charles Baker-Glenn, Alan Beresford, Daniel J. Burdick, Mark Chambers, Bryan K. Chan, Huifen Chen, Xiao Ding, Antonio G. DiPasquale, Sara L. Dominguez, Jennafer Dotson, Jason Drummond, Michael Flagella, Sean Flynn, Reina Fuji, Andrew Gill, Janet Gunzner-Toste, Seth F. Harris, Timothy P. Heffron, Tracy Kleinheinz, Donna W. Lee, Claire E. Le Pichon, Joseph P. Lyssikatos, Andrew D. Medhurst, John G. Moffat, Susmith Mukund, Kevin Nash, Kimberly Scearce-Levie, Zejuan Sheng, Daniel G. Shore, Thuy Tran, Naimisha Trivedi, Shumei Wang, Shuo Zhang, Xiaolin Zhang, Guiling Zhao, Haitao Zhu & Zachary K. Sweeney. (2012) Discovery of Highly Potent, Selective, and Brain-Penetrable Leucine-Rich Repeat Kinase 2 (LRRK2) Small Molecule Inhibitors. Journal of Medicinal Chemistry 55:22, pages 9416-9433.
Crossref
Crossref
Tatiana D. Papkovskaia, Kai-Yin Chau, Francisco Inesta-Vaquera, Dmitri B. Papkovsky, Daniel G. Healy, Koji Nishio, James Staddon, Michael R. Duchen, John Hardy, Anthony H.V. Schapira & J. Mark Cooper. (2012) G2019S leucine-rich repeat kinase 2 causes uncoupling protein-mediated mitochondrial depolarization. Human Molecular Genetics 21:19, pages 4201-4213.
Crossref
Crossref
Shani Bialik & Adi Kimchi. (2012) Biochemical and functional characterization of the ROC domain of DAPK establishes a new paradigm of GTP regulation in ROCO proteins. Biochemical Society Transactions 40:5, pages 1052-1057.
Crossref
Crossref
F Damm, F Nguyen-Khac, M Fontenay & O A Bernard. (2012) Spliceosome and other novel mutations in chronic lymphocytic leukemia and myeloid malignancies. Leukemia 26:9, pages 2027-2031.
Crossref
Crossref
Huifen Chen, Bryan K. Chan, Jason Drummond, Anthony A. Estrada, Janet Gunzner-Toste, Xingrong Liu, Yichin Liu, John Moffat, Daniel Shore, Zachary K. Sweeney, Thuy Tran, Shumei Wang, Guiling Zhao, Haitao Zhu & Daniel J. Burdick. (2012) Discovery of Selective LRRK2 Inhibitors Guided by Computational Analysis and Molecular Modeling. Journal of Medicinal Chemistry 55:11, pages 5536-5545.
Crossref
Crossref
Patricia L. Martínez-Morales & Isabel Liste. (2012)
Stem Cells as
In Vitro
Model of Parkinson's Disease
. Stem Cells International 2012, pages 1-7.
Crossref
Crossref